{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:03:58Z","timestamp":1770455038224,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,8]]},"DOI":"10.7759\/cureus.87500","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:41:37Z","timestamp":1751949697000},"source":"Crossref","is-referenced-by-count":1,"title":["Cross-Regional Comparison of Type 2 Inflammatory Markers in Chronic Rhinosinusitis With Nasal Polyposis: Insights From the Gulf Region and Canada"],"prefix":"10.7759","author":[{"given":"Ali A","family":"Al-Fraihat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah I","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandra","family":"Endam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iyad","family":"Hamadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-017-0157-8","article-title":"Endotype-driven treatment in chronic upper airway diseases","volume":"7","author":"De Greve G","year":"2017","unstructured":"De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017, 7:22. 10.1186\/s13601-017-0157-8","journal-title":"Clin Transl Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert C","year":"2015","unstructured":"Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J Allergy Clin Immunol. 2015, 136:1431-40. 10.1016\/j.jaci.2015.10.010","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin18.061","article-title":"Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study","volume":"57","author":"Ostovar A","year":"2019","unstructured":"Ostovar A, Fokkens WJ, Vahdat K, Raeisi A, Mallahzadeh A, Farrokhi S. Epidemiology of chronic rhinosinusitis in Bushehr, southwestern region of Iran: a GA2LEN study. Rhinology. 2019, 57:43-8. 10.4193\/Rhin18.061","journal-title":"Rhinology"},{"key":"ref4","unstructured":"GCC (2024) member states. (2024). Accessed. July 31, 2024: https:\/\/www.gcc-sg.org\/en-us\/Pages\/default.aspx."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.08.004","article-title":"Chronic rhinosinusitis: epidemiology and medical management","volume":"128","author":"Hamilos DL","year":"2011","unstructured":"Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011, 128:693-707. 10.1016\/j.jaci.2011.08.004","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040715","article-title":"The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis","volume":"13","author":"Seah JJ","year":"2023","unstructured":"Seah JJ, Thong M, Wang Y. The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13040715","journal-title":"Diagnostics (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens WW","year":"2015","unstructured":"Stevens WW, Ocampo CJ, Berdnikovs S, et al.. Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease. Am J Respir Crit Care Med. 2015, 192:682-94. 10.1164\/rccm.201412-2278OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a\u00a0multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang X","year":"2016","unstructured":"Wang X, Zhang N, Bo M, et al.. Diversity of T(H) cytokine profiles in patients with chronic rhinosinusitis: a\u00a0multicenter study in Europe, Asia, and Oceania. J Allergy Clin Immunol. 2016, 138:1344-53. 10.1016\/j.jaci.2016.05.041","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.489","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023","volume":"61","author":"Fokkens WJ","year":"2023","unstructured":"Fokkens WJ, Viskens AS, Backer V, et al.. EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023, 61:194-202. 10.4193\/Rhin22.489","journal-title":"Rhinology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato A","year":"2022","unstructured":"Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022, 77:812-26. 10.1111\/all.15074","journal-title":"Allergy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang N","year":"2008","unstructured":"Zhang N, Van Zele T, Perez-Novo C, et al.. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008, 122:961-8. 10.1016\/j.jaci.2008.07.008","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-009-0626-9","article-title":"Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans","volume":"125","author":"Boss\u00e9 Y","year":"2009","unstructured":"Boss\u00e9 Y, Bacot F, Montpetit A, et al.. Identification of susceptibility genes for complex diseases using pooling-based genome-wide association scans. Hum Genet. 2009, 125:305-18. 10.1007\/s00439-009-0626-9","journal-title":"Hum Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21289","article-title":"Active smoking status in chronic rhinosinusitis is associated with higher serum markers of inflammation and lower serum eosinophilia","volume":"4","author":"Berania I","year":"2014","unstructured":"Berania I, Endam LM, Filali-Mouhim A, Boisvert P, Boulet LP, Boss\u00e9 Y, Desrosiers M. Active smoking status in chronic rhinosinusitis is associated with higher serum markers of inflammation and lower serum eosinophilia. Int Forum Allergy Rhinol. 2014, 4:347-52. 10.1002\/alr.21289","journal-title":"Int Forum Allergy Rhinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100647","article-title":"Severe asthma treatment patterns: a multicenter observational study in the Gulf region","volume":"15","author":"Al-Ahmad M","year":"2022","unstructured":"Al-Ahmad M, Mobayed H, Al Busaidi N, et al.. Severe asthma treatment patterns: a multicenter observational study in the Gulf region. World Allergy Organ J. 2022, 15:100647. 10.1016\/j.waojou.2022.100647","journal-title":"World Allergy Organ J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/antib12040070","article-title":"Elevated IgE levels-an allergy or an underlying inborn error of immunity in children with recurrent infections?","volume":"12","author":"Kostova P","year":"2023","unstructured":"Kostova P, Papochieva V, Miteva D, et al.. Elevated IgE levels-an allergy or an underlying inborn error of immunity in children with recurrent infections?. Antibodies (Basel). 2023, 12:10.3390\/antib12040070","journal-title":"Antibodies (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0621-9","article-title":"Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT\u00a0program","volume":"18","author":"Tarraf H","year":"2018","unstructured":"Tarraf H, Aydin O, Mungan D, et al.. Prevalence of asthma among the adult general population of five Middle Eastern countries: results of the SNAPSHOT\u00a0program. BMC Pulm Med. 2018, 18:68. 10.1186\/s12890-018-0621-9","journal-title":"BMC Pulm Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-00485-3","article-title":"Developments in asthma incidence and prevalence in Alberta between 1995 and 2015","volume":"16","author":"Bosonea AM","year":"2020","unstructured":"Bosonea AM, Sharpe H, Wang T, Bakal JA, Befus AD, Svenson LW, Vliagoftis H. Developments in asthma incidence and prevalence in Alberta between 1995 and 2015. Allergy Asthma Clin Immunol. 2020, 16:87. 10.1186\/s13223-020-00485-3","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord ID","year":"2012","unstructured":"Pavord ID, Korn S, Howarth P, et al.. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012, 380:651-9. 10.1016\/S0140-6736(12)60988-X","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019","article-title":"Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis","volume":"10","author":"Wechsler ME","year":"2022","unstructured":"Wechsler ME, Klion AD, Paggiaro P, et al.. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2022, 10:2695-709. 10.1016\/j.jaip.2022.05.019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.133.7.701","article-title":"Total IgE levels and peripheral eosinophilia: correlation with mucosal disease based on computed tomographic imaging of the paranasal sinus","volume":"133","author":"Poznanovic SA","year":"2007","unstructured":"Poznanovic SA, Kingdom TT. Total IgE levels and peripheral eosinophilia: correlation with mucosal disease based on computed tomographic imaging of the paranasal sinus. Arch Otolaryngol Head Neck Surg. 2007, 133:701-4. 10.1001\/archotol.133.7.701","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/380080-cross-regional-comparison-of-type-2-inflammatory-markers-in-chronic-rhinosinusitis-with-nasal-polyposis-insights-from-the-gulf-region-and-canada","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:41:39Z","timestamp":1751949699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/380080-cross-regional-comparison-of-type-2-inflammatory-markers-in-chronic-rhinosinusitis-with-nasal-polyposis-insights-from-the-gulf-region-and-canada"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.87500","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,8]]}}}